Events
How to Practice Evidence-Based Health Care 26th - 28th March 2012 This workshop is intended to serve as an introduction to evidence-based practice. It is aimed at clinicians and other health care professionals (including those involved in the field of mental health) who wish to gain knowledge of critical appraisal and experience in the practice of evidence-based health care. You should consider attending if you:
More information and details on how to apply can be found at www.cebm.net ____________________________________________________________________________________ |
THIS EVENT IS PASSED
'Evaluating the evidence for Diagnostic Tests'. How can we improve bench to bedside process?
A full day of presentations, workshops and shared ideas from industry and health care
Fiday November 11th 2011 -St Annes college - Oxford
Conference presentations below
- The NICE Diagnostics Assessment Programme_Nick Crabb
- TheTechnology Strategy Board_Penny Wilson
- Commissioning Diagnostic Services_Chris Price
- Framework for Evaluating Diagnostic Tests_Patrick Bossuyt
- Evidence Requirement for IVDs_DavidOwolabi
- IVDs Evidence - Use Risk Model_David Horne
- New Technologies selfmonitoring chronic disease management_Lionel Taressenko
Papers of interest:
J Clin Epidemiol. 2011 Oct 15.
Abstract
OBJECTIVE:To estimate the number of randomized controlled trials (RCTs) published annually that evaluate the impact of diagnostic tests on patient outcomes to gauge the extent of available randomized evidence assessing the effectiveness of diagnostic tests.
STUDY DESIGN AND SETTING:
Relevant RCTs published in 2004-2007 were identified from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL). Two search strategies were developed, one using diagnostic methodological terms and one using test names. Potentially relevant RCTs were identified by screening titles and abstracts. Final inclusion decisions were based on full-text review. A random 10% sample of all citations was independently screened by a second reviewer. Capture-recapture methodology was used to estimate the number of relevant RCTs missed by both searches.
RESULTS:
One hundred thirty-five relevant RCTs were identified from the 23,888 records retrieved. Interobserver agreement was substantial. Capture-recapture methodology estimated that 148 (95% confidence interval: 140, 160) relevant RCTs were published in the 4-year period, an average of only 37 publications per year.
CONCLUSION:
RCTs of diagnostic tests that evaluate patient outcomes are rare. Consequently recommendations on the use of diagnostic tests can rarely be made on the basis of randomized comparisons, lower grade evidence frequently being the best available.
______________________________________________________________________________________________________
Dr Thierry Buclin, PD MER - This event is passed.
Division De Pharmacologie et Toxicology cliniques, Centre Hospitalier Universitaine Vaudois, Lausanne- Switzerland
Will be giving the annual MaDOx talk
Therapeutic monitoring of long-term critical therapies : the examples of HIV infection and chronic leukemia
4pm on Friday June 17th
Rewley House Lecture Theatre, 1 Wellington Square, Oxford , Ox1 2JA
______________________________________________________________________________________________________
May 12, 2011 This workshop is passed.
FDA Public Workshop on Study Methodology for Diagnostics in the Postmarket Setting
FDA White Oak Building 31, Silver Spring, MD
FDA Diagnostic Workshop Agenda.pdf
______________________________________________________________________________________________________
On Thursday April 14th at 6pm Dr Nick Crabb, Associate Director, NICE will be giving a public talk on ‘The NICE Diagnostics Assessment Programme’ at Rewley House, Wellington Square , Oxford. - This talk is passed.
Nick Crabb joined NICE in January 2010 following a 20 year career in analytical science, process technology and general management in the chemical, pharmaceutical and contract laboratory industries.
At NICE, Nick is responsible for the establishment and management of the new Diagnostics Assessment Programme.
The talk will last for approximately 45 minutes followed by a Q&A session for a further 15 minutes.
We hope to see you there.
_______________________________________________________________________________________________________
The Oxford Centre for Evidence Based Medicine and Department of Continuing Education will present a course on Evidence-Based Diagnosis and Screening from 11 - 15 April 2011 in Oxford. - This course is passed.
The course is led by Annette Pluddemann and will run over the full 5 days and will enable participants to critically appraise and apply, at an advanced level, the best evidence on diagnostic tests. The following topics will be included:
• Diagnostic Decision Making - Dr. Carl Heneghan, Director of the Centre for Evidence-Based Medicine and Clinical Reader;
• Roles of tests; Reliability and Validity, Calculation of Post-test probabilities - Prof. Paul Glasziou, Visiting Professor in the Department of Primary Health Care and Director of Bond University Centre for Research in Evidence-Based Practice (CREBP), Australia;
• Appraisal of Diagnostic Studies - Dr. Matthew Thompson, Senior Clinical Scientist and Co-Director of the Oxford Centre for Monitoring and Diagnosis(MaDOx);
• Systematic Reviews of Diagnostic Studies and Visualising results of Diagnostic accuracy tests - Dr. Clare Bankhead, University Research Lecturer and Dr. Susan Mallett, Senior Medical Statistician;
• Searching for Diagnostic Studies – Nia Roberts, Outreach Librarian and Honorary Senior Research Fellow in the Centre for Evidence-Based Medicine;
• Screening - Dr. Amanda Burls, Director of Postgraduate Programmes in Evidence-Based Health Care and Senior Fellow of the Centre for Evidence-Based Medicine;
• Multiple tests and Diagnostic Pathway - Dr. Ann van den Bruel, Academic Clinical Lecturer;
• Rational Monitoring - Dr. Richard Stevens, University Research Lecturer in Statistics;
• Commissioning Diagnostic Services - Prof. Christopher P Price, Professor in Clinical Biochemistry and Clinical Director of the Cumbria and Lancashire Pathology Commissioning Network;
• Diagnostic Horizon Scanning - Dr. Annette Pluddemann, Director for the Horizon Scanning Programme Oxford;
The Invited Guest Speaker will be Dr. Nick Crabb, Associate Director of the National Institute for Health and Clinical Excellence (NICE) Diagnostics Assessment Programme
This module can be taken as a standalone course or used as credit for the EBHC Masters course.
Click here for further information, Admissions Criteria and How to Apply
______________________________________________________________________________________________________
Self monitoring blood glucose in non-insulin treated type 2 diabetes
2nd December 2010
Rhodes House, University of Oxford - This conference is passed.
Objective: to present up to date information of what is known about SMBG and in particular explore if it is likely to be effective in selected groups
Conference poster - SMBG Poster.pdf
Conference presentations -
IPD SM of BG-Rafael Perera(2).pdf
Mechanisms of action-Bill Polonsky(2).pdf
Future policy-Simon Heller(2).pdf
Current and FutureTechnology-Lionel Tarassenko(2).pdf
The Patient's Perspective-HugoTewson(1).pdf
A qualitative perspective-Julia Lawton(2).pdf
Alternative types of monitoring-Stuart Smellie(1).pdf
______________________________________________________________________________________________________
Interational Working Group on Clinical Prediction Rules
29 - 30th September 2010
Somerville College, Oxford - This meeting is passed.
Objective: to seek CPRs for which there is evidence of impact on clinical practice: for example, incorporation into major clinical guidelines, and to identify characteristics of these 'successful' CPRs
Tom Fahey - Rafael Perera - Richard Stevens
.jpg)